Stocks
USANA Health Sciences (USNA) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 13.0% | 10.1% | 13.4% | 11.6% | 8.87% | 7.80% | ||
| Changes by years, y/y, % | +2pp | -3pp | +3pp | -2pp | -3pp | -12.9% | |||
USANA Health Sciences. EBITDA margin, %
USANA Health Sciences. EBITDA margin, changes, pp
USANA Health Sciences (USNA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 12.2% | 5.34% | 6.45% | 9.46% | 9.46% | 7.80% | |
| Changes by years, y/y, % | +1pp | -7pp | -1pp | -2pp | -2pp | |||
| Changes by quarters, q/q, % | +1pp | -7pp | +1pp | +3pp | 0pp | |||
